Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephane Laframboise

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Gynecologic Oncology|July 16, 2014
The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancerBarry Rosen, Stephane Laframboise, Sarah Ferguson, et al.
Journal of Lower Genital Tract Disease|July 31, 2015
Malignant Melanoma of Vulva and Vagina: A Histomorphological Review and Mutation Analysis--A Single-Center StudyMarjan Rouzbahman, Suzanne Kamel-Reid, Ayman Al Habeeb, et al.
Gynecologic Oncology|February 25, 2014
Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestinAndrea N Simpson, Tomer Feigenberg, Blaise A Clarke, et al.
Journal of Surgical Oncology|November 17, 2021
Treatment outcomes and predictive factors in patients ≥70 years old with advanced ovarian cancerSabrina Piedimonte, Marcus Q Bernardini, Taymaa May, et al.
Gynecologic Oncology|October 31, 2025
Description of first recurrence in advanced stage high grade serous ovarian cancer receiving intraperitoneal versus intravenous systemic treatmentAuni Lindgren, Anouk Benseler, Liat Hogen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 4, 2023
Validation of the Integrated Prediction Model algorithm for outcome of cytoreduction in advanced ovarian cancerSabrina Piedimonte, Marcus Q Bernardini, Avrilynn Ding, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 12, 2025
Erratum to 'Factors influencing surgeons' decision for diverting ileostomy and associated complications in ovarian cancer cytoreductive surgery' [International Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101640]Liat Hogen, Thirushi Siriwardena, Lina Salman, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|December 16, 2020
The impacts of neoadjuvant chemotherapy and of cytoreductive surgery on 10-year survival from advanced ovarian cancerSoyoun Rachel Kim, Joanne Kotsopoulos, Ping Sun, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|May 31, 2016
The optimal time for surgery in women with serous ovarian cancerJocelyn M Stewart, Alicia A Tone, Haiyan Jiang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 15, 2025
Factors influencing surgeons' decision for diverting ileostomy and associated complications in ovarian cancer cytoreductive surgeryLiat Hogen, Thirushi Siriwardena, Lina Salman, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Gynecologic Oncology|July 16, 2014
The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancerBarry Rosen, Stephane Laframboise, Sarah Ferguson, et al.
Journal of Lower Genital Tract Disease|July 31, 2015
Malignant Melanoma of Vulva and Vagina: A Histomorphological Review and Mutation Analysis--A Single-Center StudyMarjan Rouzbahman, Suzanne Kamel-Reid, Ayman Al Habeeb, et al.
Gynecologic Oncology|February 25, 2014
Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestinAndrea N Simpson, Tomer Feigenberg, Blaise A Clarke, et al.
Journal of Surgical Oncology|November 17, 2021
Treatment outcomes and predictive factors in patients ≥70 years old with advanced ovarian cancerSabrina Piedimonte, Marcus Q Bernardini, Taymaa May, et al.
Gynecologic Oncology|October 31, 2025
Description of first recurrence in advanced stage high grade serous ovarian cancer receiving intraperitoneal versus intravenous systemic treatmentAuni Lindgren, Anouk Benseler, Liat Hogen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 4, 2023
Validation of the Integrated Prediction Model algorithm for outcome of cytoreduction in advanced ovarian cancerSabrina Piedimonte, Marcus Q Bernardini, Avrilynn Ding, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 12, 2025
Erratum to 'Factors influencing surgeons' decision for diverting ileostomy and associated complications in ovarian cancer cytoreductive surgery' [International Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101640]Liat Hogen, Thirushi Siriwardena, Lina Salman, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|December 16, 2020
The impacts of neoadjuvant chemotherapy and of cytoreductive surgery on 10-year survival from advanced ovarian cancerSoyoun Rachel Kim, Joanne Kotsopoulos, Ping Sun, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|May 31, 2016
The optimal time for surgery in women with serous ovarian cancerJocelyn M Stewart, Alicia A Tone, Haiyan Jiang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 15, 2025
Factors influencing surgeons' decision for diverting ileostomy and associated complications in ovarian cancer cytoreductive surgeryLiat Hogen, Thirushi Siriwardena, Lina Salman, et al.
Pageof 6